Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations
about
Robust tumor immunity to melanoma mediated by interleukin-9-producing T cellsThe development and in vivo function of T helper 9 cellsCapturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancerHuman longevity and variation in GH/IGF-1/insulin signaling, DNA damage signaling and repair and pro/antioxidant pathway genes: cross sectional and longitudinal studiesEvaluation of TRAF6 in a large multiancestral lupus cohortConstitutional promoter methylation and risk of familial melanomaSerum levels of interleukin-9 correlate with negative prognostic factors in extranodal NK/T-cell lymphoma.Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case-control study.Genetic variants in DNA repair genes and the risk of cutaneous malignant melanoma in melanoma-prone families with/without CDKN2A mutations.Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.TH9 cells in anti-tumor immunity.IL-9 and Th9 cells in health and diseases-From tolerance to immunopathology.Th9 Cells: New Member of T Helper Cell Family.Amazing IL-9: revealing a new function for an "old" cytokinePhenocopies in melanoma-prone families with germ-line CDKN2A mutations.Interleukin 12B rs3212227 T > G polymorphism was associated with an increased risk of gastric cardiac adenocarcinoma in a Chinese population.Transcriptional Control of Th9 Cells: Role of Foxo1 in Interleukin-9 Induction.
P2860
Q24601213-B6E8FC08-47F0-44A9-A27D-4FB12D4E093AQ28083375-E2C1C55E-FA13-4B2A-9764-D23F9BF89BE9Q28238393-99E5DE66-20E2-4B68-8465-B1B299E08C12Q30513719-869C9639-7207-4BA0-8DD3-C0CA5D8FC289Q33399089-49F9E072-6CFB-4897-AAFD-2F0601DDE2C3Q33779164-C9CAF35A-6FBD-4F48-88E2-0AA233E1561EQ35145308-1A113BF0-46F0-46EE-B1CF-A3BEEB4A21D8Q35674748-2EC56CE1-E93D-47A4-B12D-3C4590D37E17Q35742829-70D03E52-BADF-4982-9BDB-6BF66989C7C5Q36599686-08F88444-60CB-437F-8036-137DDBCDC75AQ37575177-93B11ECB-1827-4BD0-AEE5-39EABCE44C11Q39454903-0A5335C4-8ED8-4706-AECE-CF5D54BF22A1Q40224209-6A2E1D66-95DE-43EF-9950-C51554D6E44AQ41626243-B19A326F-1F4D-4722-AA39-5E0B573FE0C6Q47351477-7F344F48-DC0F-42EC-8869-CC87590B8751Q51160668-3856B881-62E4-4911-93C0-0B64390E73B7Q55280345-16F4103A-8CB7-480D-85BA-D2AF5FE068B7
P2860
Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of modifier gen ...... h and without CDKN2A mutations
@en
Identification of modifier gen ...... and without CDKN2A mutations.
@nl
type
label
Identification of modifier gen ...... h and without CDKN2A mutations
@en
Identification of modifier gen ...... and without CDKN2A mutations.
@nl
prefLabel
Identification of modifier gen ...... h and without CDKN2A mutations
@en
Identification of modifier gen ...... and without CDKN2A mutations.
@nl
P2093
P2860
P356
P1476
Identification of modifier gen ...... h and without CDKN2A mutations
@en
P2093
Alisa M Goldstein
Margaret A Tucker
Ruth M Pfeiffer
William Wheeler
Xiaohong Rose Yang
P2860
P304
P356
10.1002/IJC.24622
P577
2009-12-01T00:00:00Z